Abstract:NALFD is becoming a global epidemic with severe complications, but few if any pharmacological therapies are available. Owing to its unique anatomy, microarchitecture, and cellular composition, the liver functions as an immune organ in addition to its roles in metabolism and detoxification. Innate immune signaling controls both inflammatory and metabolic profiles in the liver, and has potential to provide novel therapeutic targets in non-alcoholic steatohepatitis (NASH). Innate immune components mediate both canonical inflammation cascades and noncanonical metabolism-related pathways by modulating post-translational modifications or transcriptional coregulation, thus controlling NASH progression. Multi-omic analyses, cell signaling, and tissue-specific gene-editing technologies, combined with advances in disease models, will facilitate in-depth understanding of NAFLD and the discovery of new drugs. Non-alcoholic fatty liver disease (NAFLD) has become the most epidemic liver disease worldwide owing to rapid changes in lifestyle over the past few decades. This chronic condition intertwines with low-grade inflammation and metabolic disequilibrium, and potentiates the onset and progression of devastating hepatic and extrahepatic complications. In addition to an integral role in promoting host defense, recent studies also implicate innate immune signaling in a multitude of processes that control the progression of NAFLD. The focus of this review is to highlight emerging evidence regarding the role of innate immunity in NAFLD and the integration of different pathways that affect both inflammation and metabolism across the spectrum of this liver morbidity. Non-alcoholic fatty liver disease (NAFLD) has become the most epidemic liver disease worldwide owing to rapid changes in lifestyle over the past few decades. This chronic condition intertwines with low-grade inflammation and metabolic disequilibrium, and potentiates the onset and progression of devastating hepatic and extrahepatic complications. In addition to an integral role in promoting host defense, recent studies also implicate innate immune signaling in a multitude of processes that control the progression of NAFLD. The focus of this review is to highlight emerging evidence regarding the role of innate immunity in NAFLD and the integration of different pathways that affect both inflammation and metabolism across the spectrum of this liver morbidity.

The Role of Innate Immune Cells in Nonalcoholic Steatohepatitis

Roles of Hepatic Innate and Innate-Like Lymphocytes in Nonalcoholic Steatohepatitis

The Role of Innate Immune Cells in Nonalcoholic Fatty Liver Disease

Role of Innate Immune Signaling in Non-Alcoholic Fatty Liver Disease

The role of immune cells in metabolism-related liver inflammation and development of non-alcoholic steatohepatitis (NASH)

Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH

Immune cell-mediated features of non-alcoholic steatohepatitis

Pathogenesis of Nonalcoholic Steatohepatitis: An Overview

Innate immunity and nonalcoholic fatty liver disease

Innate Immune Regulatory Networks in Hepatic Lipid Metabolism

Innate Immune Signaling in Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases.

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications

Molecular mechanisms of metabolic disease-associated hepatic inflammation in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis

Role of immune responses in the development of NAFLD-associated liver cancer and prospects for therapeutic modulation

Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes

The Role of the Intestinal Microbiota in Nonalcoholic Steatohepatitis

Microbiota‐Driven Activation of Intrahepatic B Cells Aggravates NASH Through Innate and Adaptive Signaling

Expansion of Macrophage and Liver Sinusoidal Endothelial Cell Subpopulations During Non-Alcoholic Steatohepatitis Progression

Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions